Oral Technologies News Today

Catalent, Inc. Share Price Target '$57.32', now .7% Upside Potential

Catalent, Inc. Share Price Target '$48.57', now 6.7% Upside Potential

Catalent, Inc. (NYSE:CTLT – Free Report) – Investment analysts at Zacks Research dropped their Q3 2025 EPS estimates for shares of Catalent in a report released on Monday, December 18th. Zacks Research analyst D. Dey now forecasts that the company will post earnings per share of $0.53 for the quarter, down from their previous estimate […]

Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have earned an average recommendation of “Hold” from the twelve research firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, six have given a hold recommendation and five have given a buy recommendation to the company. The […]

StockNews.com upgraded shares of Catalent (NYSE:CTLT – Free Report) to a sell rating in a research note released on Friday. A number of other equities analysts have also recently issued reports on CTLT. Barclays dropped their price target on shares of Catalent from $55.00 to $50.00 and set an equal weight rating on the stock […]

Clearfield Capital Management LP acquired a new stake in shares of Catalent, Inc. (NYSE:CTLT – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 291,800 shares of the company’s stock, valued at approximately $12,652,000. Catalent comprises about 10.3% of Clearfield Capital Management LP’s […]

Clearfield Capital Management LP acquired a new stake in Catalent, Inc. (NYSE:CTLT – Free Report) in the second quarter, HoldingsChannel.com reports. The firm acquired 291,800 shares of the company’s stock, valued at approximately $12,652,000. Catalent makes up about 10.3% of Clearfield Capital Management LP’s investment portfolio, making the stock its 3rd largest position. A number […]

Coliseum Capital Management LLC acquired a new position in shares of Catalent, Inc. (NYSE:CTLT – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 848,300 shares of the company’s stock, valued at approximately $36,782,000. Catalent makes up 3.3% of Coliseum […]

Mcmorgan & Co. LLC increased its stake in Catalent, Inc. (NYSE:CTLT – Free Report) by 5.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,940 shares of the company’s stock after purchasing an additional 2,065 shares during the period. Mcmorgan & […]

Catalent, Inc. (NYSE:CTLT – Get Free Report) saw a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 10,700,000 shares, an increase of 5.9% from the October 31st total of 10,100,000 shares. Based on an average daily trading volume, of 2,440,000 shares, the days-to-cover ratio […]